nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—TNF—Crohn's disease	0.13	1	CrCbGaD
Bupranolol—ADRB2—Arf6 trafficking events—VAMP3—Crohn's disease	0.11	0.127	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0223	0.0256	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0191	0.022	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0181	0.0208	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 trafficking events—ITGA4—Crohn's disease	0.0169	0.0194	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—PTGER4—Crohn's disease	0.0154	0.0176	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.0146	0.0168	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ACKR2—Crohn's disease	0.0145	0.0167	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—MLN—Crohn's disease	0.0138	0.0159	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0136	0.0157	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0132	0.0152	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0129	0.0149	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0125	0.0144	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0117	0.0134	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0113	0.013	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0111	0.0127	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0107	0.0124	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0105	0.0121	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.0097	0.0112	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR9—Crohn's disease	0.00956	0.011	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00911	0.0105	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00891	0.0102	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—GPR65—Crohn's disease	0.00888	0.0102	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00869	0.01	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ACKR2—Crohn's disease	0.00863	0.00992	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00854	0.00982	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.0085	0.00978	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ACKR2—Crohn's disease	0.00844	0.00971	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00831	0.00956	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—MLN—Crohn's disease	0.00818	0.00941	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00808	0.00929	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—MLN—Crohn's disease	0.008	0.0092	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00791	0.00909	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—MLN—Crohn's disease	0.00779	0.00896	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ACKR2—Crohn's disease	0.00746	0.00858	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00745	0.00856	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00732	0.00841	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00729	0.00838	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MLN—Crohn's disease	0.00708	0.00813	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00692	0.00796	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00677	0.00779	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR6—Crohn's disease	0.00633	0.00728	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00576	0.00662	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR9—Crohn's disease	0.00567	0.00652	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00563	0.00648	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—PTGER4—Crohn's disease	0.00557	0.00641	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR9—Crohn's disease	0.00555	0.00638	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR9—Crohn's disease	0.0054	0.00621	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—GPR65—Crohn's disease	0.00527	0.00606	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—GPR65—Crohn's disease	0.00516	0.00593	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00507	0.00583	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—GPR65—Crohn's disease	0.00502	0.00577	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00496	0.0057	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00493	0.00567	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR9—Crohn's disease	0.0049	0.00564	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00483	0.00555	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—MLN—Crohn's disease	0.00462	0.00532	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GPR65—Crohn's disease	0.00456	0.00524	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.00452	0.0052	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ACKR2—Crohn's disease	0.00443	0.00509	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ACKR2—Crohn's disease	0.00441	0.00507	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00434	0.00499	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.00433	0.00498	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00425	0.00489	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MLN—Crohn's disease	0.0042	0.00483	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MLN—Crohn's disease	0.00418	0.00481	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.00411	0.00472	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAGAP—Crohn's disease	0.00382	0.00439	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR6—Crohn's disease	0.00376	0.00432	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.00368	0.00423	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR6—Crohn's disease	0.00358	0.00411	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RSPO3—Crohn's disease	0.00334	0.00384	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—PTGER4—Crohn's disease	0.00331	0.0038	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR6—Crohn's disease	0.00325	0.00373	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.00324	0.00372	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR9—Crohn's disease	0.00321	0.00369	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SEL1L—Crohn's disease	0.00317	0.00364	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00315	0.00362	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.00314	0.0036	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GPR65—Crohn's disease	0.00298	0.00343	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.00292	0.00335	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR9—Crohn's disease	0.00291	0.00335	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR9—Crohn's disease	0.0029	0.00333	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PTGER4—Crohn's disease	0.00286	0.00329	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	0.00285	0.00327	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GPR65—Crohn's disease	0.00271	0.00311	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GPR65—Crohn's disease	0.00269	0.0031	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL3—Crohn's disease	0.00268	0.00308	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00268	0.00308	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	0.00265	0.00304	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ACKR2—Crohn's disease	0.00262	0.00301	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00259	0.00298	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	0.00256	0.00294	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MLN—Crohn's disease	0.00248	0.00285	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL3—Crohn's disease	0.00244	0.0028	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MLN—Crohn's disease	0.00243	0.00279	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—RASGRP1—Crohn's disease	0.00236	0.00271	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	0.00227	0.00261	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	0.00222	0.00255	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	0.00212	0.00244	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.00208	0.00239	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL8—Crohn's disease	0.00204	0.00235	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	0.00198	0.00228	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	0.00194	0.00223	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	0.00193	0.00222	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR6—Crohn's disease	0.00192	0.00221	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	0.00189	0.00217	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	0.00188	0.00216	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL2RA—Crohn's disease	0.00188	0.00216	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00187	0.00215	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	0.00184	0.00211	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00183	0.0021	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RBX1—Crohn's disease	0.00174	0.002	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR9—Crohn's disease	0.00172	0.00198	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL2RA—Crohn's disease	0.00171	0.00196	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	0.0017	0.00195	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTGER4—Crohn's disease	0.00169	0.00194	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR9—Crohn's disease	0.00168	0.00193	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.00166	0.00191	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GPR65—Crohn's disease	0.0016	0.00184	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	0.00159	0.00183	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00159	0.00183	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GPR65—Crohn's disease	0.00156	0.0018	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	0.00156	0.00179	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00156	0.00179	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00154	0.00177	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—UBE2D1—Crohn's disease	0.00152	0.00175	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00151	0.00173	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RIPK2—Crohn's disease	0.00148	0.0017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL3—Crohn's disease	0.00145	0.00166	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL3—Crohn's disease	0.00144	0.00165	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL3—Crohn's disease	0.00141	0.00163	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	0.0014	0.00161	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RASGRP1—Crohn's disease	0.00139	0.0016	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00137	0.00157	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—JAK2—Crohn's disease	0.00126	0.00145	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SOCS1—Crohn's disease	0.00126	0.00145	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	0.00121	0.00139	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TYK2—Crohn's disease	0.0012	0.00138	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.00118	0.00136	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL8—Crohn's disease	0.00115	0.00133	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—JAK2—Crohn's disease	0.00115	0.00132	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR6—Crohn's disease	0.00114	0.00131	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00112	0.00128	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR6—Crohn's disease	0.00111	0.00128	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.00109	0.00125	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SMAD3—Crohn's disease	0.00109	0.00125	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—Crohn's disease	0.00105	0.0012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RBX1—Crohn's disease	0.00103	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	0.00101	0.00116	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2RA—Crohn's disease	0.00101	0.00116	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RBX1—Crohn's disease	0.00101	0.00116	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	0.001	0.00115	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.000991	0.00114	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	0.000981	0.00113	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	0.000903	0.00104	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	0.000884	0.00102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	0.000876	0.00101	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	0.000857	0.000985	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL3—Crohn's disease	0.000854	0.000982	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL3—Crohn's disease	0.000836	0.000961	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	0.000826	0.00095	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000808	0.000929	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	0.00075	0.000862	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	0.000748	0.000861	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	0.000733	0.000843	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	0.000732	0.000842	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	0.000714	0.00082	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TYK2—Crohn's disease	0.00071	0.000817	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	0.000698	0.000803	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000684	0.000787	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	0.000681	0.000783	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JAK2—Crohn's disease	0.000678	0.000779	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000669	0.00077	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	0.000666	0.000766	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	0.000646	0.000743	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	0.000632	0.000727	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	0.000621	0.000714	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—Crohn's disease	0.000618	0.000711	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	0.000608	0.000699	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	0.000598	0.000688	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—Crohn's disease	0.000588	0.000676	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	0.000585	0.000673	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT3—Crohn's disease	0.000497	0.000572	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TYK2—Crohn's disease	0.000422	0.000485	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TYK2—Crohn's disease	0.000412	0.000474	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JAK2—Crohn's disease	0.000402	0.000462	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JAK2—Crohn's disease	0.000393	0.000452	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	0.000367	0.000422	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	0.000359	0.000413	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—Crohn's disease	0.000349	0.000401	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—Crohn's disease	0.000347	0.000399	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—Crohn's disease	0.000341	0.000393	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT3—Crohn's disease	0.000295	0.000339	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT3—Crohn's disease	0.000289	0.000332	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—Crohn's disease	0.000206	0.000237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—Crohn's disease	0.000202	0.000232	CbGpPWpGaD
